Infectious Diseases (all articles)
COVID-19 vaccine-linked adenopathies could mimic breast malignancies
2 Feb, 2021 | 01:17h | UTCCOVID-19 Vaccine-Linked Adenopathies Could Mimic Breast Malignancies – Diagnostic Imaging
Original Study: Unilateral axillary Adenopathy in the setting of COVID-19 vaccine – Clinical Imaging
Commentaries on Twitter
Important for radiologists to consider vaccine induced hyperplastic adenopathy in unilateral axillary adenopathy seen on #breastimaging post #COVID19Vaccine #COVID19
Read here https://t.co/7IizHgIzU0@NishiMehtaMD @KatiaDodelzon @KemiMDRad @WCMRadiology @BreastImaging
— Clinical Imaging (@CI_Journal) January 19, 2021
The COVID-19 vaccine may cause swollen lymph nodes that could be mistaken for breast malignancies. However, it's important not to postpone your vaccine or breast cancer screenings, researchers from @WCMRadiology and @WCMBreastCenter say. https://t.co/jLuVbA2rXL
— Weill Cornell Medicine (@WeillCornell) January 22, 2021
Study estimates vaccines against 10 pathogens prevented 37 million deaths in low- and middle-income countries in the last 20 years
1 Feb, 2021 | 01:44h | UTCCommentaries: Vaccines work: a reason for celebration and renewed commitment – The Lancet AND Study estimates that, without vaccination against 10 diseases, mortality in children under five would be 45% higher in low-income and middle-income countries – The Lancet AND Vaccines against 10 diseases prevented 37 million deaths in low- and middle-income countries in the last 20 years – London School of Hygiene & Tropical Medicine
Commentary on Twitter
NEW—Study estimates from 2000-2030, #vaccination against 10 major pathogens will have prevented 69 million deaths in low/middle-income countries (LMICs). Without vaccination, mortality in children under 5 would be 45% higher in LMICS. Read: https://t.co/S4JXOqdctU pic.twitter.com/MF8W25nDJJ
— The Lancet (@TheLancet) January 28, 2021
[Not published yet] Full-dose Heparin best for moderate COVID-19 regardless of D-dimer — Data released from ACTIV-4a, ATTACC, and REMAP-CAP trials
1 Feb, 2021 | 01:58h | UTCFull-Dose Heparin Best for Moderate COVID-19 Regardless of D-dimer — Data released from ACTIV-4a, ATTACC, and REMAP-CAP trials – MedPage Today (free registration required)
Trial results: ATTACC, ACTIV-4a & REMAP-CAP multiplatform RCT Results of interim analysis – ATTACC Trial
New Updates to the Surviving Sepsis Campaign COVID-19 Guidelines
1 Feb, 2021 | 01:56h | UTCAdditional resources: COVID-19 Guidelines – Surviving Sepsis Campaign
Commentary on Twitter
New updates to the #SurvivingSepsis Campaign #COVID19 Guidelines! Includes new recommendations for therapeutics and defines severe vs critical COVID-19.
View the full update in @CritCareMed, more infographics, and recommendations table here: https://t.co/OUuOwGJCR4#SCCMSoMe pic.twitter.com/1RGckdvoIm
— SCCM (@SCCM) January 30, 2021
Analysis: J&J and Novavax Data
1 Feb, 2021 | 01:54h | UTCJ&J and Novavax Data – In the Pipeline
[Press release – not published yet] Single-shot Janssen COVID-19 vaccine candidate met primary endpoints in interim analysis of its phase 3 trial
1 Feb, 2021 | 01:55h | UTCCommentaries: J&J’s one-shot COVID vaccine offers hope for faster protection – Nature AND Johnson & Johnson Executive Says Vaccine Works Where It Counts: Preventing Deaths – NPR AND Novavax’s COVID Vaccine Shows High Efficacy In Trials; J&J One-Dose Shot Less So – As Europe Feuds With AstraZeneca – Health Policy Watch AND Covid vaccine: Single-dose Johnson & Johnson jab is 66% effective – BBC AND Johnson & Johnson’s COVID-19 Vaccine Results Are Better Than They May Sound – TIME AND Expert reaction to Johnson & Johnson announcing that the single-shot Janssen COVID-19 vaccine candidate met primary endpoints in the interim analysis of its phase 3 ENSEMBLE Trial – Science Media Centre AND Janssen Investigational COVID-19 Vaccine: Interim Analysis of Phase 3 Clinical Data Released – NIH News Releases AND J&J one-dose Covid vaccine is 66% effective, a weapon but not a knockout punch – STAT
SARS-CoV-2 vaccines and the growing threat of viral variants
1 Feb, 2021 | 01:50h | UTCSARS-CoV-2 Vaccines and the Growing Threat of Viral Variants – JAMA
How to redesign COVID vaccines so they protect against variants: lineages that can evade immunity are spurring vaccine makers to explore ways to redesign their shots
1 Feb, 2021 | 01:52h | UTCHow to redesign COVID vaccines so they protect against variants – Nature
See also: Vaccine 2.0: Moderna and other companies plan tweaks that would protect against new coronavirus mutations – Science (a few articles per month are free)
The most worrying mutations in five emerging coronavirus variants
1 Feb, 2021 | 01:50h | UTCThe Most Worrying Mutations in Five Emerging Coronavirus Variants – Scientific American
Analysis: Covid-19 pandemic and the social determinants of health
1 Feb, 2021 | 01:49h | UTCCovid-19 pandemic and the social determinants of health – The BMJ
Public health actions to control new SARS-CoV-2 variants
1 Feb, 2021 | 01:47h | UTCPublic health actions to control new SARS-CoV-2 variants – Cell
Commentary on Twitter (thread – click for more)
*Public health actions to control new SARS-CoV-2 variants*
Our paper just published in @CellCellPress w wonderful co-authors @NathanGrubaugh @firefoxx66 @JosephFauver & @mugecevik
We describe actions govts should urgently take to protect health.
— Dr Alexandra Phelan (@alexandraphelan) January 29, 2021
Explaining covid-19 performance: 10 factors might predict national responses
1 Feb, 2021 | 01:48h | UTCExplaining covid-19 performance: what factors might predict national responses? – The BMJ
Commentary on Twitter
The Global Health Security Index did not predict which countries would do well (or badly) in pandemic. Our new paper, led by @baumfran @bmj_latest gives 10 reasons why, & points to factors that are importanthttps://t.co/sVYGw1TFCR
— Martin McKee (@martinmckee) January 29, 2021
WHO issues new 10-year plan to end suffering from neglected tropical diseases
29 Jan, 2021 | 01:39h | UTCNews release: WHO issues new 10-year plan to end suffering from neglected tropical diseases – World Health Organization
Report, executive summary and more: Ending the neglect to attain the Sustainable Development Goals: A road map for neglected tropical diseases 2021–2030 – World Health Organization
Commentary on Twitter (thread – click for more)
In 1⃣ decade, significant progress was achieved to #beatNTDs, with 42 countries ? eliminating at least 1 disease.
The ? roadmap for neglected tropical diseases 2021-2030 builds on this success to ↗️ progress & to contribute to reaching @GlobalGoalsUN
?https://t.co/tsd5FP3z01 pic.twitter.com/6ydlIZBElp
— World Health Organization (WHO) (@WHO) January 28, 2021
WHO announces updated definitions of extensively drug-resistant tuberculosis
29 Jan, 2021 | 01:38h | UTC
New coronavirus variants call for intensified surveillance, control, and vaccination efforts
29 Jan, 2021 | 01:56h | UTCNew coronavirus variants call for intensified surveillance, control, and vaccination efforts – STAT
Opinion: We need an equitable and coordinated global approach to covid-19 vaccination
29 Jan, 2021 | 01:57h | UTCWe need an equitable and coordinated global approach to covid-19 vaccination – The BMJ Opinion
Related: WHO chief warns against ‘catastrophic moral failure’ in COVID-19 vaccine access (commentaries on the subject)
“Until there is an international consensus and coordinated operational strategy, the virus will find new vulnerable populations and continue to spread.”
Editorial: How epidemiology has shaped the COVID pandemic
29 Jan, 2021 | 01:58h | UTCHow epidemiology has shaped the COVID pandemic – Nature
Some European countries move to require medical-grade masks in public
29 Jan, 2021 | 01:49h | UTCSome European Countries Move To Require Medical-Grade Masks In Public – NPR
How Covid-19 mutations are changing the pandemic
29 Jan, 2021 | 01:55h | UTCHow Covid-19 mutations are changing the pandemic – BBC
Novavax says its Covid-19 vaccine is 90% effective, but far less so against one variant
29 Jan, 2021 | 01:50h | UTCNovavax says its Covid-19 vaccine is 90% effective, but far less so against one variant – STAT
German officials say AstraZeneca vaccine shouldn’t be given to over-65s, citing lack of data
29 Jan, 2021 | 01:52h | UTCGerman officials say AstraZeneca vaccine shouldn’t be given to over-65s, citing lack of data – CNN
Patients with heart failure hospitalized with COVID-19 are at high risk for complications, with nearly 1 in 4 dying during hospitalization
29 Jan, 2021 | 01:46h | UTC
Cohort study: Schizophrenia linked to increased mortality among patients with COVID-19
29 Jan, 2021 | 01:47h | UTCAssociation of Psychiatric Disorders With Mortality Among Patients With COVID-19 – JAMA Psychiatry
Commentaries: Expert reaction to COVID and schizophrenia – Science Media Centre AND Schizophrenia Second Only To Age as Greatest Risk Factor for COVID-19 Death – NYU Langone Health
Why you should still wear a mask and avoid crowds after getting the COVID-19 vaccine
29 Jan, 2021 | 01:48h | UTCWhy You Should Still Wear A Mask And Avoid Crowds After Getting The COVID-19 Vaccine – NPR
WHO recommends the Dapivirine vaginal ring as a new choice for HIV prevention for women at substantial risk of HIV infection
28 Jan, 2021 | 01:22h | UTC
Commentary on Twitter
Good news: @WHO recommends an additional #HIV prevention tool for women at substantial risk for the infection: They can now choose to use the dapivirine vaginal ring (DPV-VR) as part of a combination of prevention approaches. https://t.co/YmW6KzAojx
— Tedros Adhanom Ghebreyesus (@DrTedros) January 27, 2021